These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 2713554

  • 1. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A, Barbui T, Boccadoro M, Comotti B, Dammacco F, Gallamini A, Marmont F, Neretto G, Petrucci MT, Resegotti L.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract] [Full Text] [Related]

  • 2. [Chemotherapy of multiple myeloma].
    Golenkov AK.
    Sov Med; 1991 Jan; (3):43-6. PubMed ID: 1882290
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C, Sevilla F, Zapatero A, Blanco L, Sabán J, Serrano M, Serrano Ríos M.
    Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
    [No Abstract] [Full Text] [Related]

  • 4. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M, Frikha M, Masmoudi H, Mseddi S, Ben Ayed M, Bouaziz M, Makni F, Souissi T.
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
    Montalbán C, Zapatero A, Blanco L, Sevilla F, García Laraña J, Odriozola J.
    Sangre (Barc); 1984 Apr; 29(6):993-9. PubMed ID: 6549486
    [No Abstract] [Full Text] [Related]

  • 6. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
    Yang X, Yang C, Shao K, Ye X, Meng H, Zhou Y, Qian W.
    Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
    [No Abstract] [Full Text] [Related]

  • 7. [Pneumonia caused by Salmonella in a patient with myeloma].
    Fernández P, Roldán V, García MC, Gil MT, Rivas C.
    Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
    [No Abstract] [Full Text] [Related]

  • 8. [Autograft and multiple myeloma: experience of the Intergroupe Français du Myélome].
    Attal M, Harousseau JL.
    Bull Cancer; 2001 Sep; 88(9):888-92. PubMed ID: 11604362
    [Abstract] [Full Text] [Related]

  • 9. [Intracytoplasmic crystals and Fanconi syndrome in a patient with IgA kappa myeloma].
    Martín Reyes G, García González I, Alférez MJ, Martínez González JM, Frutos MA.
    Nefrologia; 2001 Sep; 21(2):213-6. PubMed ID: 11464657
    [Abstract] [Full Text] [Related]

  • 10. [Results with the use of the M-2 protocol in plasmacytoma].
    Ho AD, Wittkamp S, Theml H, Keilholz U, Hunstein W.
    Dtsch Med Wochenschr; 1986 May 30; 111(22):858-61. PubMed ID: 3754811
    [Abstract] [Full Text] [Related]

  • 11. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
    Morstyn G, Schechter GP, Ihde DC, Carney DN, Eddy JL, Cohen MH, Minna JD, Bunn PA.
    Cancer Treat Rep; 1984 Dec 30; 68(12):1439-46. PubMed ID: 6391662
    [Abstract] [Full Text] [Related]

  • 12. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J, Bladé J, Lahuerta JJ, Ribera JM, Martínez R, Alegre A, García-Laraña J, Fernández P, Sureda A, de Arriba F, Carrera D, Besalduch J, García Boyero R, Palomera Bernal L, Hernández MT, García PR, Pérez-Calvo J, Alcalá A, Casado LF, San Miguel J.
    Haematologica; 2006 May 30; 91(5):621-7. PubMed ID: 16627253
    [Abstract] [Full Text] [Related]

  • 13. [The influence of verapamil on platelet function in patients with multiple myeloma].
    Sokołowska B, Dmoszyńska A, Walter-Croneck A, Wojtaszko M.
    Pol Merkur Lekarski; 1997 Feb 30; 2(8):109-10. PubMed ID: 9538652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myeloma and related disorders.
    Kyle RA, Durie BG, Boccadoro M, Pavlovsky S.
    Rev Invest Clin; 1994 Apr 30; Suppl():46-51. PubMed ID: 7886308
    [No Abstract] [Full Text] [Related]

  • 18. Expression of BAX in plasma cell dyscrasias.
    Renner S, Weisz J, Krajewski S, Krajewska M, Reed JC, Lichtenstein A.
    Clin Cancer Res; 2000 Jun 30; 6(6):2371-80. PubMed ID: 10873089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
    Lila AM, Mazurov VI, Novik AA.
    Ter Arkh; 1997 Jun 30; 69(2):50-2. PubMed ID: 9173578
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.